RxDoctor Payments Data

Howard Kaye

Rheumatology · Vista, CANPI 1457361446

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Amgen at 32.6% of the total. Reporting peaked in 2023 at $1,048 and has fallen 98.3% since, to $18 in 2024. That places this record below the midpoint for rheumatology clinicians in CA, where the typical reported total is $1,724.

$1,961in general payments, 2019–2025

Across 110 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$639
  • AbbVie$305
  • Novartis$173
  • Aurinia Pharma U.S., Inc.$137
  • GSK$125
  • Lilly USA, LLC$103
  • plus $479 from 11 others

What the payments were for

  • Food & beverage$1,94199%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,961 in reported general payments places this provider in the 50th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Other rheumatology in Vista

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →